03/16/2026
Heart disease is still the #1 cause of death in the United States. That’s why earlier detection and treatment of cholesterol matters.
New guidance from the American College of Cardiology (ACC) and American Heart Association (AHA) places more emphasis on advanced markers like lipoprotein(a) [Lp(a)] and apolipoprotein B [apoB], which can reveal cardiovascular risk that a standard cholesterol panel may miss.
At Sparrow Family Medicine, we’ve already been taking this proactive approach — using advanced testing when appropriate and focusing on earlier identification and treatment of elevated cholesterol.
Statins remain the gold standard therapy for lowering LDL cholesterol and have decades of evidence showing they significantly reduce the risk of heart attack and stroke.
Our goal is simple: find risk earlier, treat it appropriately, and keep our patients heart-healthy for the long run.